| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |